Loading…
Alaunos Therapeutics Inc Is A Preclinical-Stage Biopharmaceutical Company Focused On The Development Of Novel, Orally Administered Small-Molecule Therapeutics For Obesity And Related Metabolic Disorders, Such As Metabolic Dysfunction-Associated Steatotic Liver Disease (Masld, A Type Of Fatty Liver Disease). The Program Aims To Develop A Differentiated, Non-Hormonal, Non-Incretin Approach, Unlike Hormone-Based Treatments Like Glp-1 Drugs. It Has A Single Reportable And Operating Segment Related To Biopharmaceutical Research And Development.